Publication
Asia M&A trends: Future outlook
Whilst global M&A rose in deal value terms in 2024, both deal values and volumes fell in most parts of Asia.
Mitigating tariff risks for healthcare in US and Canada
Law 360
The US and Canada have healthcare, life science and medical device industries that are complex and interconnected.
On March 6, President Donald Trump instituted a 25 percent ad valorem rate of duty on goods imported from Canada under the International Emergency Economic Powers Act.[1] The tariffs will not be implemented on goods that comply with the United States-MexicoCanada Agreement until April 2.[2] In turn, Canada has announced a $155 billion tariff package on the US.[3]
Download the full Law360 article, "Mitigating Tariff Risks For Healthcare In US And Canada."
Partner
Email
jeff.wurzburg@nortonrosefulbright.com
Recent publications
Subscribe and stay up to date with the latest legal news, information and events . . .